Prio Wealth Limited Partnership’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.49M Sell
55,515
-1,898
-3% -$111K 0.1% 96
2024
Q2
$3.39M Buy
57,413
+600
+1% +$37.5K 0.1% 96
2024
Q1
$4.53M Sell
56,813
-3,047
-5% -$233K 0.13% 90
2023
Q4
$4.73M Sell
59,860
-2,468
-4% -$176K 0.16% 83
2023
Q3
$4.35M Sell
62,328
-2,005
-3% -$142K 0.17% 82
2023
Q2
$4.45M Sell
64,333
-3,747
-6% -$267K 0.16% 83
2023
Q1
$5.06M Sell
68,080
-1,025
-1% -$86K 0.19% 79
2022
Q4
$6.44M Sell
69,105
-868
-1% -$83.8K 0.26% 77
2022
Q3
$6.67M Sell
69,973
-2,818
-4% -$279K 0.29% 73
2022
Q2
$6.74M Sell
72,791
-605
-0.8% -$59K 0.27% 74
2022
Q1
$7.43M Sell
73,396
-293
-0.4% -$30.8K 0.25% 77
2021
Q4
$7.6M Sell
73,689
-2,031
-3% -$188K 0.23% 78
2021
Q3
$6.43M Sell
75,720
-693
-0.9% -$58K 0.22% 80
2021
Q2
$6.38M Sell
76,413
-1,247
-2% -$102K 0.21% 80
2021
Q1
$5.84M Sell
77,660
-950
-1% -$69.2K 0.21% 80
2020
Q4
$5.37M Buy
78,610
+1,084
+1% +$70.5K 0.2% 78
2020
Q3
$4.53M Buy
77,526
+25
+0% +$1.56K 0.19% 77
2020
Q2
$5.04M Sell
77,501
-530
-0.7% -$33.4K 0.23% 74
2020
Q1
$4.63M Sell
78,031
-5,106
-6% -$341K 0.26% 71
2019
Q4
$6.18M Sell
83,137
-7,520
-8% -$528K 0.26% 76
2019
Q3
$5.72M Buy
90,657
+615
+0.7% +$36.4K 0.26% 77
2019
Q2
$4.91M Sell
90,042
-6,251
-6% -$337K 0.23% 81
2019
Q1
$5.19M Sell
96,293
-16,836
-15% -$1.04M 0.24% 79
2018
Q4
$7.41M Buy
113,129
+11,354
+11% +$848K 0.4% 68
2018
Q3
$8.01M Sell
101,775
-2,650
-3% -$189K 0.37% 71
2018
Q2
$6.72M Sell
104,425
-2,141
-2% -$141K 0.33% 73
2018
Q1
$6.63M Sell
106,566
-14,563
-12% -$1.04M 0.33% 74
2017
Q4
$8.78M Sell
121,129
-6,449
-5% -$469K 0.41% 70
2017
Q3
$10.4M Sell
127,578
-2,450
-2% -$194K 0.51% 56
2017
Q2
$10.5M Sell
130,028
-209,830
-62% -$16.6M 0.52% 54
2017
Q1
$26.7M Buy
339,858
+19,763
+6% +$1.58M 1.37% 26
2016
Q4
$25.3M Sell
320,095
-84,283
-21% -$6.82M 1.35% 26
2016
Q3
$36M Sell
404,378
-1,264
-0.3% -$119K 1.91% 11
2016
Q2
$38.8M Sell
405,642
-1,755
-0.4% -$175K 2.13% 8
2016
Q1
$42.3M Buy
407,397
+2,529
+0.6% +$246K 2.31% 7
2015
Q4
$39.6M Buy
404,868
+7,017
+2% +$687K 2.16% 10
2015
Q3
$38.4M Buy
397,851
+21,615
+6% +$2.27M 2.18% 9
2015
Q2
$39.5M Buy
376,236
+123,809
+49% +$12.6M 2.03% 12
2015
Q1
$26.1M Sell
252,427
-5,745
-2% -$581K 1.29% 25
2014
Q4
$24.9M Sell
258,172
-6,755
-3% -$595K 1.24% 26
2014
Q3
$21.1M Sell
264,927
-5,158
-2% -$407K 1.09% 32
2014
Q2
$20.4M Sell
270,085
-15,359
-5% -$1.16M 1.03% 35
2014
Q1
$21.4M Sell
285,444
-6,125
-2% -$433K 1.08% 33
2013
Q4
$20.9M Sell
291,569
-6,146
-2% -$395K 1.05% 33
2013
Q3
$16.9M Sell
297,715
-21,775
-7% -$1.3M 0.96% 40
2013
Q2
$18.3M Buy
+319,490
New +$18.5M 1.1% 32

Other funds holding CVS

Prio Wealth Limited Partnership's CVS Position: Q3 2024 in Review

Prio Wealth Limited Partnership reduced its CVS Health (CVS) stake by 3.3% in Q3 2024, selling an estimated $111K and leaving 55,515 shares worth $3.49M. The position accounts for 0.1% of the portfolio, ranked #96.

Prio Wealth Limited Partnership first reported a position in CVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $42.3M in Q1 2016. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Prio Wealth Limited Partnership held 55,515 shares of CVS Health worth $3.49M as of Q3 2024.
  • Prio Wealth Limited Partnership sold 1,898 CVS Health shares in Q3 2024, an estimated $111K.
  • CVS Health made up 0.1% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #96 holding.
  • Prio Wealth Limited Partnership first reported a position in CVS Health in Q2 2013 and has held it in 46 quarters since.
  • Prio Wealth Limited Partnership's CVS Health position peaked at $42.3M in Q1 2016.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.